FDA Approves Eticovo (etanercept-ykro), a Biosimilar to Enbrel

INCHEON, Korea– As of April 2019– Samsung Bioepis Co., Ltd. today announced that the US Food and Drug Administration (FDA) has approved Eticovo (etanercept-ykro), a biosimilar referencing Enbrel (etanercept), across all eligible...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news